We were the first to show that decreased expression of BRCA1 occurs in sporadic breast cancer at the transition from ductal carcinoma in situ to invasive ductal carcinoma, and that experimental knockdown of BRCA1 expression leads to accelerated growth of both normal and malignant mammary epithelial cells [35]. The gene discussed is BRCA1; the disease is invasive ductal breast carcinoma.